Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.

Human immunodeficiency virus type 1 (HIV-1) appears to adversely affect hepatitis C, but whether hepatitis C virus (HCV) has a reciprocal effect on HIV-1 infection remains a point of controversy. In a multivariate analysis of a cohort of 5832 individuals, we found that individuals coinfected with HCV and HIV-1 (prevalence of coinfection, 5.8%) had a CD4+ cell count that decreased at a rate similar to that for individuals infected with HIV-1 alone. However, coinfection was associated with a statistically significant increased likelihood of onset of an acquired immunodeficiency syndromedefining illness or developing a CD4+ cell count of <200 cells/mm3, compared with infection with HIV-1 alone (hazard ratio, 1.52; 95% confidence interval, 1.072.17). Patients who were naive to highly active antiretroviral therapy were significantly less likely to progress to either end point, because of their higher CD4+ cell counts. In conclusion, there was an increased number of adverse events in coinfected individuals, compared with individuals infected with HIV-1 alone.

[1]  Michael S Saag,et al.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[2]  Michael S Saag,et al.  Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel , 2006 .

[3]  R. Hershow,et al.  Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  K. Sherman,et al.  CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. , 2005, The Journal of infectious diseases.

[5]  C. Hung,et al.  Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection , 2005, International journal of STD & AIDS.

[6]  E. Daar,et al.  Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. , 2005, The Journal of infectious diseases.

[7]  D. Vlahov,et al.  The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy , 2004, AIDS.

[8]  J. Guest,et al.  Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  N. Voirin,et al.  Survival in HIV‐infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database , 2004, Journal of viral hepatitis.

[10]  B. Gazzard,et al.  Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients , 2004, Cell Research.

[11]  K. Ruxrungtham,et al.  Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort , 2004, AIDS.

[12]  D. Pillay,et al.  HIV and hepatitis C coinfection within the CAESAR study , 2004, HIV medicine.

[13]  B. Gazzard,et al.  Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. , 2004, Blood.

[14]  Martin S. Hirsch,et al.  Treatment for adult HIV infection. , 2004 .

[15]  P. Morlat,et al.  Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) , 2003, AIDS.

[16]  E. Ribera,et al.  Hepatitis C virus and human immunodeficiency virus coinfection in Spain. , 2003, The Journal of infection.

[17]  Y. Lo,et al.  The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. , 2003, Journal of acquired immune deficiency syndromes.

[18]  S. Suissa,et al.  The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. , 2003, Journal of acquired immune deficiency syndromes.

[19]  D. Dieterich,et al.  Toxicity of non-nucleoside analogue reverse transcriptase inhibitors. , 2003, Seminars in liver disease.

[20]  M. Sulkowski Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors , 2003, Seminars in liver disease.

[21]  A. Moorman,et al.  Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Macías,et al.  Mortality due to Liver Failure and Impact on Survival of Hepatitis Virus Infections in HIV-Infected Patients Receiving Potent Antiretroviral Therapy , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  P. Easterbrook,et al.  Hepatitis C and HIV-1 coinfection , 2002, Gut.

[24]  George Y Wu,et al.  Hepatitis C and HIV co-infection: a review. , 2002, World journal of gastroenterology.

[25]  Richard D Moore,et al.  Hepatitis C and progression of HIV disease. , 2002, JAMA.

[26]  P. Volberding,et al.  Does hepatitis C virus infection increase the risk of HIV disease progression? , 2002, JAMA.

[27]  P. Couzigou,et al.  Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? , 2002, AIDS.

[28]  A. Gervais [Chronic hepatitis C in HIV-HCV coinfected patients]. , 2002, Gastroenterologie clinique et biologique.

[29]  I. Bica,et al.  Risk of HAART therapy in hepatitis C , 2002, Hepatology.

[30]  R. Chaisson,et al.  Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: Role of hepatitis C and B infections , 2002, Hepatology.

[31]  Harpreet K. Monga,et al.  Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  M. Battegay,et al.  Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study , 2000, The Lancet.

[33]  D. Vlahov,et al.  The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.

[34]  C. Tsoukas,et al.  Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. , 1999, The Journal of infectious diseases.

[35]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[36]  S. Darby,et al.  Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C , 1997, The Lancet.

[37]  C. Sabin,et al.  The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. , 1997, The Journal of infectious diseases.

[38]  A. Phillips,et al.  Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. , 1995, The Journal of infectious diseases.

[39]  P. Bacchetti,et al.  Hepatitis C in HIV‐infected patients with and without AIDS: Prevalence and relationship to patient survival , 1994, Hepatology.

[40]  M. Krajden,et al.  Hepatitis C virus infection in patients infected with the human immunodeficiency virus. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.